Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × Everolimus × Clear all

NCT00886691 2022-02-04

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase 2 Completed

150 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02283658 2020-10-23

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Phase 2 Completed

20 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01031381 2016-08-30

RADBEV

Phase 2 Completed

50 enrolled 7 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Recurrence